EMEA-002541-PIP01-18

Key facts

Active substance
  • Rosuvastatin (calcium)
  • Ezetimibe
Therapeutic area
Cardiovascular diseases
Decision number
P/0259/2019
PIP number
EMEA-002541-PIP01-18
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of elevated cholesterol
Route(s) of administration
Oral use
Contact for public enquiries
Abbott Laboratories Limited

Tel.  +44 (0) 1628 644513
E-mail: robyn.hall@abbott.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating